IV levetiracetam in the management of non-convulsive status epilepticus

Neurocritical Care

Volumn 7, Issue 1, 2007, Pages 36-39

  Farooq, Muhammad U ^a,b   Naravetla, Bharath ^a,b   Majid, Arshad ^a,b   Gupta, Rishi ^a,b   Pysh, Joseph J ^a,b   Kassab, Mounzer Y ^a,b  

^a East Lansing   (United States)

^b Sparrow Healthcare System ^*  (United States)

Author keywords

Intravenous levetiracetam; Non convulsive status epilepticus

Indexed keywords

ETIRACETAM; PHENYTOIN;

AGED; ANAMNESIS; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CASE REPORT; CLINICAL FEATURE; COMPLEX PARTIAL SEIZURE; COMPUTER ASSISTED TOMOGRAPHY; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; HUMAN; LABORATORY TEST; MALE; PRIORITY JOURNAL;

AGED, 80 AND OVER; ANTICONVULSANTS; ELECTROENCEPHALOGRAPHY; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PIRACETAM; STATUS EPILEPTICUS;

EID: 36949033153     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-007-0022-z     Document Type: Article

References (7)

1. Patel NC, Landan IR, Levin J, Szaflarski J, Wilner AN. The use of levetiracetam in refractory status epilepticus. Seizure 2006;15(3):137-41.
2. Rossetti AO, Bromfield EB. Levetiracetam in the treatment of status epilepticus in adults: a study of 13 episodes. Eur Neurol 2005;54(1):34-8.
3. Rupprecht S, Franke K, Fitzek S, Witte OW, Hagemann G. Levetiracetam as a treatment option in non-convulsive status epilepticus. Epilepsy Res 2006.
4. Ramael S, Daoust A, Otoul C, et al. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia. 2006;47(7):1128-35.
5. Gillard M, Chatelain P, Fuks B. Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein. Eur J Pharmacol 2006;536(1-2):102-8.
6. Loscher W, Honack D, Rundfeldt C. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. J Pharmacol Exp Ther 1998;284(2):474-9.
7. Dedeurwaerdere S, Vonck K, De Herdt V, et al. Neuromodulation with levetiracetam and vagus nerve stimulation in experimental animal models of epilepsy. Acta Neurol Belg 2006;106(2):91-7.